SLE Drug Race Heats Up: 120+ Pharma Giants Develop 140+ Pipeline Therapies
Over 120 pharmaceutical companies are developing 140+ drugs for systemic lupus erythematosus, with major players like Roche and Novartis advancing promising new treatment mechanisms.
JNJABBVNVSRHHBYAZN+3FDA approvalclinical trials